» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 426-450 of 1083 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Determination of the efficacy and safety of IVIG in treatment of patients with COVID-19 (...) : Masih Daneshvari Hospital. How to do the study: 80 patients with COVID-19 will be randomly divided in to (...) COVID-19 by RT-PCR test, who are severely ill, and are between 18 to 65 years old. Patients with oxygen
IRCTID: IRCT20151227025726N20
Study aim: Evaluation of the effect of Levamisole on treatment of the patients with COVI-19 infection Design: In this study every patient with diagnosis of COVID-19 and with sign and symptoms will be (...) and exclusion criteria: the patients with COVID 19 infection Intervention groups: In this study the
IRCTID: IRCT20181208041886N1
Study aim: Evaluation the effect of minocycline in covid-19 patients Design: A randomized, blinded, placebo controlled clinical trial with a parallel group design of 40 patients, randomizing with the table (...) , 40 patients with covid-19 disease were selected and randomly assigned to two groups of 20 individuals
IRCTID: IRCT20081019001369N4
criteria are adults over the age of 18 with a diagnosis of COVID-19 clinical criteria (presence of any symptoms of cough, shortness of breath, fever, and CT scan of the lung for evidence of COVID-19 infection (...) patients with Quid 19 compared with placebo Design: This study is a randomized, double-blind clinical
IRCTID: IRCT20190804044429N4
was performed in selected outpatient treatment centers of Covid-19 in Shiraz among patients who have (...) clinical manifestations of Covid-19 disease in the age group of 18 to 80 years. Exclusion criteria: Patients with severe clinical signs and symptoms of Covid-19, patients with HIV, patients with severe
IRCTID: IRCT20210213050344N1
control group in patients with Covid 19 undergoing respiratory support admitted to the intensive care unit (...) softwere was used for randomization. Settings and conduct: Patients with Covid 19 admitted to the (...) Covid 19 with positive PCR or CT scan, hospitalized in the intensive care unit, patient is receiving non
IRCTID: IRCT20200612047740N4
  1. Comparison of efficacy and complications of NIPPV vs NCPAP in preterm infants with respiratory distress admitted in NICU
  2. The Efficacy of Noninvasive Cycled-PAP in the Management of Respiratory Distress Syndrome in Infants with a Gestational Age of 28 to 32 Weeks: NIPPV Vs. Synchronized-NIPPV; A Clinical Trial
  3. Comparing two methods of non invasive ventilatory support: nasal contentious positive airway pressure (nCPAP) and nasal intermittent positive pressure ventilation (NIPPV) in preterm infants
  4. Comparison of two methods of respiratory support: Nasal Continuous positive Airway Pressure (NCPAP) and Nasal Intemitant Positive Pressure Ventilation (NIPPV) after less invasive surfactant administration (LISA) in preterm infants 28 to 36 weeks of age with respiratory distress syndrome, a Randomized clinical trial
  5. Nasal intermittent positive ventilation (NIPPV) or conventional mechanical ventilation for treatment of neonatal respiratory failure
  6. Effect of guided imagery and progressive muscle relaxation on sedation of non invasive mechanically ventilated patients
  7. The effect of oral care using Artificial saliva to control dry mouth in patients with COVID-19 under non-invasive mechanical ventilation: A quasi-experimental study
  8. Comparing the efficacy of NCPAP and NIPPV in premature infants with RDS after extubation in NICU ward of Najmiyeh Hospital
  9. The sleep/wake cycle in newborns with 28 to 32 weeks of gestational age: A Comparative study of Nasal Continuous Positive Airway Pressure (nCPAP) and Nasal Intermittent Positive Pressure Ventilation (NIPPV)
  10. Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure
Study aim: Determining the therapeutic effect of noscapine on cough in patients with COVID-19 (...) patients with mild COVID-19 referred to the corona clinic of Masih Daneshvari Hospital were randomly (...) : Patients over 18 years of age with cough and positive RT-PCR for COVID-19 who are candidates for receiving
IRCTID: IRCT20151227025726N31
Study aim: Effect of postural drainage on physiological parameters of patients with covid-19 (...) conduct: Patients with medium to critical grade Covid-19 without intubation with respiratory symptoms in (...) . Participants/Inclusion and exclusion criteria: Inclusion criteria: Medium to critical grade Covid-19 without
IRCTID: IRCT20220618055209N1
Study aim: Improved oxygenation of patients with severe COVID-19 Design: The study was designed as a single-blind clinical trial. The study population will be patients undergoing ventilation in the (...) /Inclusion and exclusion criteria: Inclusion criteria: age over 18 y; PCR positive for COVID-19; Dyspnea
IRCTID: IRCT20210613051560N1
during non-invasive ventilation in patients with covid-19 in Hospital Design: Clinical trial with (...) . Settings and conduct: In patients admitted to the intensive care unit of Covid-19 patients, the (...) /Inclusion and exclusion criteria: Inclusion criteria: Conscious patients with Covid-19 undergoing non
IRCTID: IRCT20171002036498N5
reducing intraoral viral load among patients with COVID-19 Design: This is a double-blind randomized (...) control groups Settings and conduct: The eligible patients with COVID-19 referring to the Sina Hospital (...) to moderate Covid-19 disease; Need for hospitalization; Exclusion criteria: Pregnancy or
IRCTID: IRCT20120215009014N398
  1. Evaluation of the Effectiveness of Mouthwashes in Early Reducing the mouth Viral Load Among COVID-19 Patients: A double-blind randomized clinical trial
  2. Evaluating the effect of gargling with Hydrogen Peroxide 1% and Povidine Iodine 0.25% on viral load of SARS-CoV-2 in covid19 patients ; A pilot randomized clinical trial
  3. Antibacterial effect of sodium hypochlorite 6% plus chlorhexidine 0.2% and calcium hydroxide powder versus sodium hypochlorite 6% alone on the endodontic lesion in patients with apical periodontitis: a double blind randomized clinical trial
  4. Effect of licorice mouthwash versus chlorhexidine mouthwash on oral health in intubated patients in intensive care unit: a double-blind randomized clinical trial
  5. Comparative study of the effect of two solutions of Chlorhexidine and sodium bicarbonate mouthwash on the onset of Covid-19 related symptoms in vaccinated operating room staff
  6. Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity
  7. Comparison of the effect of green tea mouthwash with normal saline on swelling and pain caused by impacted wisdom tooth surgery in patients
  8. Effect of Diphenhydramine Mouthwash on pain during inferior alveolar nerve block injection: a clinical trial study
  9. Effect of local injection of botulinum toxin versus nasal fluticasone spray on clinical sign and symptoms in patients with allergic rhinitis: a triple blind randomized clinical trial
  10. Comparison of the effect of marshmallow and eucalyptus nebulizer on cough intensity among patients with COVID-19 disease
Study aim: The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19 Design: This study is a one-blind randomized clinical trial, without (...) patients with COVID-19 treated in Yazd in the summer of 1400 with lung involvement proven on radiography
IRCTID: IRCT20210513051275N1
symptoms of patients with COVID-19 Design: This phase 3 clinical trial is performed in a double-blind method on 100 patients with Covid 19 virus. 100 patients are randomly assigned to 50 blocks including 2 (...) is one week. Settings and conduct: 100 patients with Covid virus 19 referred to Farabi and Golestan
IRCTID: IRCT20130722014106N9
Study aim: Evaluation of the therapeutic effect of Simospan syrup (contains Thymus vulgaris, Hedera helix, Honey, and Vitamin C) on the duration of hospitalization of covid-19 patients Design: The (...) : hospitalized patients diagnosed with covid-19; age between 30-60 years; the amount of oxygen saturation below
IRCTID: IRCT20210621051642N1
  1. Comparing the effect of topical 1% Hedera helix L. extract gel with 1% Diclofenac gel in the treatment of patients with primary knee osteoarthritis referred to orthopedic clinic
  2. Comparing the effect of Topical 1% Hedera helix L. Extract gel and 1% Diclofenac gel in the Treatment of Primary Knee Osteoarthritis Patients
  3. effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19
  4. Interventional study of intravenous vitamin C in definitive patients with covid 19 and its effect on changes in lung CT scan and clinical and laboratory symptoms of patients
  5. The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19)
  6. Comparison the Effect of Thymus Vulgaris and Purslane (Portulaca Oleracea) Ointment on the painintensity during cannulation
  7. Evaluation and comparison of the effectiveness of three herbal products containing Noscapine (Opiucough, Noscough and Noscatem) on clinical symptoms and para-clinical parameters in adults hospitalized with severe COVID-19
  8. The effect of combination of selenium, vitamin C and methylprednisolone in acute respiratory distress syndrome mortality and morbidity from COVID-19
  9. Evaluation of therapeutic effects of ZAX.1400.C05 on symptomatic treatment and clinical features of patients with coronavirus: a randomized controlled clinical trial
  10. Comparing the efficacy of Molnupiravir and placebo on recovery rate in patients with mild COVID-19, a randomized multicenter clinical trial
Study aim: Determining the effect of blended learning-based training on the social stigma attributed by health workers to being infected with Covid-19 in Qom province Design: The clinical trial has (...) suffering from Covid-19 Exit criteria include: having a specific disease, Intervention groups: Intervention
IRCTID: IRCT20221210056772N1
Study aim: Effect of olfactory training (OT) on olfactory disorders in patients with covid-19 (...) infected with Covid-19 (PCR positive) referred to Beheshti Hospital's treatment center who stated that they (...) entering the study: Patients with a history of being infected with Covid-19 (PCR positive) referring to
IRCTID: IRCT20221023056273N1
quality in untrained men with a history of COVID-19. Based on inclusion and exclusion criteria, purposive (...) training within the past six months, contracting the COVID-19 twelve weeks before the intervention or earlier, being diagnosed as a mild to moderate case of the COVID-19, and obtaining a total score of five
IRCTID: IRCT20230221057480N1
-intubated & awake ARDS due to COVID-19 pneumonia. Design: A clinical trial with a control group, with (...) old, confirmed COVID-19 disease, Saturation of Peripheral Oxygen < 90%, awake, able to prone position (...) of COVID-19 patients without the special facilities
IRCTID: IRCT20210724051970N1
Study aim: The effect of Famotidine on cognitive and behavioral dysfunctions induced by COVID-19 (...) will be performed on patients with COVID-19 attending Imam Khomeini Hospital in Tehran Participants/Inclusion and exclusion criteria: Inclusion criteria: History of hospitalization due to COVID-19 - At least
IRCTID: IRCT20090117001556N138
tosilizumab and baricitinib in patients with COVID-19 respiratory distress syndrome Design: A controlled (...) COVID-19 are randomly assigned to the intervention and control groups. Participants/Inclusion and exclusion criteria: Patients between the ages of 18 and 100 years who have been diagnosed with COVID-19 by
IRCTID: IRCT20151227025726N30
Study aim: The effect of Celecoxib on depression in patients with COVID-19 Design: Randomized (...) patients with depression induced by COVID-19 attending Imam Khomeini Hospital Participants/Inclusion and (...) COVID-19 - Psychosis - Any other mental disorder in another axis - Taking other psychiatric drugs which
IRCTID: IRCT20090117001556N142
  1. Lumateperone as adjuvant therapy to sertraline in major depressive disorder: A randomized double blind and placebo controlled clinical trial
  2. Evaluating the effectiveness of citalopram and sertraline in the treatment of depression with respect to the level of BDNF, IL-6, and cortisol in men and women with major depressive disorder: A randomized double-blinded clinical trial
  3. Studying the effects of Celecoxib as monotherapy in the treatment of postpartum depression with mild intensity to the average: response to treatment of Celecoxib by area Brain-Derived Neurotrophic Factor (BDNF) and inflammatory cytokines (TNFα, IFNγ , IL-1Α, IL-1Β IL-6, IL-8)
  4. Investigating the effect of Famotidine on cognitive and behavioral dysfunctions induced by COVID-19: A randomized double blind and placebo controlled clinical trial
  5. Cilostazol as adjuvant therapy to Sertraline in major depression: A randomized double blind and placebo controlled clinical trial
  6. The effect of barij deprex capsule containing Echium amoenum L and Hypericum perforatum dry extracts on mild to moderate Depression and comparison with fluoxetine
  7. Evaluation of efficacy of celecoxib as add on to risperidone to reduce positive , negative and cognitive symptoms in schizophrenic patients in active phase: a double-blind, randomized and placebo-controlled clinical trial
  8. Effects of Ginkgo biloba in depression and cognitive problems of depressed patients treated with ECT referred to the psychiatric ward in Shahrekord Hajar hospital
  9. Investigating the effect of probiotic supplementation in improving symptoms of depression, anxiety, insomnia, anorexia and cognitive impairment in HIV-positive patients, a three-blind randomized clinical trial with placebo control.
  10. Comparison of the effects of Naltrexone versus placebo on memory deficit followed by Electroconvulsive therapy in depressed patients: A double blind clinical trial
vaccination other than Covid-19 three months prior to enrollment. Intervention groups: First dose: Sinopharm
IRCTID: IRCT20131221015878N3
  1. Immunogenicity and safety of pastocovac vaccine as a booster dose in comparison with sinopharm and pastocovac Plus boosters in Iranian adults aged 18 to 80 who received 2 doses of Sinopharm vaccine: a parallel group clinical trial
  2. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  3. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  4. Comparison of immunogenicity and safety of Razi Cov Pars and Sinopharm booster doses in adults 18 years of age and older who have primarily vaccinated with Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial ‎
  5. Evaluation of the serological response to the heterologous versus homologous booster vaccinationin in patients receiving autologous hematopoietic stem cell transplantation
  6. Comparison of safety and immunogenicity of FAKHRAVAC and Sinopharm booster doses for adults 18 years of age and older, fully vaccinated by Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial
  7. A Clinical trial to evaluate the immunogenicity and safety of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of age
  8. Phase 3 Clinical Trial to evaluate the Immunogenicity and Safety of Covid19 Recombinant RBD Protein Vaccine (Noora Vaccine) as a Booster Vaccine after injection of existing Vaccines in IRAN
  9. Comparison of the safety and efficacy of Razi SARS-CoV-2 recombinant Spike protein (Razi Cov Pars) and Sinopharm vaccines in adults aged 18 and over, a phase III randomised, double blind, non-inferiority clinical trial
  10. Phase I, Randomized, Double Blind, Placebo-controlled, Study of the Safety and Immunogenicity of mRNA-based COVID-19 Vaccine (COReNAPCIN) Produced by ReNAP Co. as Booster Dose in Healthy Population Aged 18-50 Years
Study aim: Investigating the effect of Selected Breathing-Core Stabilization Tele-Exercises on Postural control, Pulmonary Function and Functional Capacity in Discharged Patients Recovered from Covid-19 (...) : Patients discharged from hospital with hospitalization due to Covid-19 From 35 years old to 60 years old
IRCTID: IRCT20211015052777N1
Study aim: The effect of pentoxifylline on hypoxia in non-intubated covid-19 patients hospitalized (...) Settings and conduct: This study is performed on patients Covid 19 admitted to the intensive care unit of (...) : Admission requirements: confirmation of Covid-19 diagnosis by PCR test informed consent to participate in
IRCTID: IRCT20210623051677N1
Loading...